Literature DB >> 3595556

In vivo labelling of intermediates in the discontinuous synthesis of mRNAs in Trypanosoma brucei.

P W Laird, J C Zomerdijk, D de Korte, P Borst.   

Abstract

Discontinuous mRNA synthesis in trypanosomes is thought to involve a 140-nucleotide precursor, called the mini-exon-derived RNA or medRNA, which contributes its 5' 35 nucleotides to the 5' end of nascent mRNAs. We used in vivo labelling of RNA to show that medRNA has a half-life of less than 6 min, whereas putative high mol. wt intermediates containing the 3' part of the medRNA have an average half-life of less than 1 min. This eliminates priming of pre-mRNA synthesis by intact medRNA as the main mode of discontinuous mRNA synthesis. Potential intermediates of 35 and 105 nucleotides were labelled in parallel with medRNA, but their significance could not be assessed in RNA preparations containing medRNA, as they are also produced by artefactual cleavage of medRNA. We show, however, that high mol. wt RNA, free of medRNA, can release medRNA segments upon a debranching treatment. These results are consistent with a trans splicing mechanism involving short-lived forked intermediates, analogous to lariats in cis splicing systems.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3595556      PMCID: PMC553502          DOI: 10.1002/j.1460-2075.1987.tb04858.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  52 in total

1.  Identification, purification and properties of clone-specific glycoprotein antigens constituting the surface coat of Trypanosoma brucei.

Authors:  G A Cross
Journal:  Parasitology       Date:  1975-12       Impact factor: 3.234

2.  A rapid alkaline extraction procedure for screening recombinant plasmid DNA.

Authors:  H C Birnboim; J Doly
Journal:  Nucleic Acids Res       Date:  1979-11-24       Impact factor: 16.971

3.  Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.

Authors:  P S Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

4.  Calcium protects DNase I from proteinase K: a new method for the removal of contaminating RNase from DNase I.

Authors:  R H Tullis; H Rubin
Journal:  Anal Biochem       Date:  1980-09-01       Impact factor: 3.365

5.  Cultivation and in vitro cloning or procyclic culture forms of Trypanosoma brucei in a semi-defined medium. Short communication.

Authors:  R Brun
Journal:  Acta Trop       Date:  1979-09       Impact factor: 3.112

6.  6.5 S RNA; preliminary characterisation of unusual small RNAs in Trypanosoma brucei.

Authors:  J S Cordingley; M J Turner
Journal:  Mol Biochem Parasitol       Date:  1980-04       Impact factor: 1.759

7.  Transcripts coding for variant surface glycoproteins of Trypanosoma brucei have a short, identical exon at their 5' end.

Authors:  J C Boothroyd; G A Cross
Journal:  Gene       Date:  1982-12       Impact factor: 3.688

8.  Determination of nucleic acid sequence homologies and relative concentrations by a dot hybridization procedure.

Authors:  F C Kafatos; C W Jones; A Efstratiadis
Journal:  Nucleic Acids Res       Date:  1979-11-24       Impact factor: 16.971

9.  Uptake of purine bases and nucleosides in African trypanosomes.

Authors:  D M James; G V Born
Journal:  Parasitology       Date:  1980-10       Impact factor: 3.234

10.  The isolation of plasmids containing DNA complementary to messenger RNA for variant surface glycoproteins of Trypanosoma brucei.

Authors:  J H Hoeijmakers; P Borst; J van den Burg; C Weissmann; G A Cross
Journal:  Gene       Date:  1980-03       Impact factor: 3.688

View more
  42 in total

1.  A new twist in trypanosome RNA metabolism: cis-splicing of pre-mRNA.

Authors:  G Mair; H Shi; H Li; A Djikeng; H O Aviles; J R Bishop; F H Falcone; C Gavrilescu; J L Montgomery; M I Santori; L S Stern; Z Wang; E Ullu; C Tschudi
Journal:  RNA       Date:  2000-02       Impact factor: 4.942

2.  SmD1 is required for spliced leader RNA biogenesis.

Authors:  Gusti M Zeiner; Silvie Foldynová; Nancy R Sturm; Julius Lukes; David A Campbell
Journal:  Eukaryot Cell       Date:  2004-02

3.  Characterization of VSG gene expression site promoters and promoter-associated DNA rearrangement events.

Authors:  K Gottesdiener; H M Chung; S D Brown; M G Lee; L H Van der Ploeg
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

4.  Trans splicing in trypanosomes requires methylation of the 5' end of the spliced leader RNA.

Authors:  E Ullu; C Tschudi
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

5.  Maturation of polycistronic pre-mRNA in Trypanosoma brucei: analysis of trans splicing and poly(A) addition at nascent RNA transcripts from the hsp70 locus.

Authors:  J Huang; L H van der Ploeg
Journal:  Mol Cell Biol       Date:  1991-06       Impact factor: 4.272

6.  Subnuclear localization of the active variant surface glycoprotein gene expression site in Trypanosoma brucei.

Authors:  I Chaves; J Zomerdijk; A Dirks-Mulder; R W Dirks; A K Raap; P Borst
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

7.  Transcription termination and 3'-End processing of the spliced leader RNA in kinetoplastids.

Authors:  N R Sturm; M C Yu; D A Campbell
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

8.  The Trypanosoma brucei protein phosphatase gene: polycistronic transcription with the RNA polymerase II largest subunit gene.

Authors:  R Evers; A W Cornelissen
Journal:  Nucleic Acids Res       Date:  1990-09-11       Impact factor: 16.971

9.  Novel and essential subunits in the 300-kilodalton nuclear cap binding complex of Trypanosoma brucei.

Authors:  Hongjie Li; Christian Tschudi
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

10.  Similarity between a ubiquitous promoter element in an ancient eukaryote and mammalian initiator elements.

Authors:  D V Quon; M G Delgadillo; A Khachi; S T Smale; P J Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.